WMA Declaration of Helsinki – Ethical Principles f... ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Ask the Heart Doctor | Heart Valve Disease and Sur...
Drug candidate slows motor neuron disease progress...
A Professional Overview of Hypertension ...
Long-term physical activity protects against metabolic syndr...
January 17,2026
Controlling hypertension can reduce dementia risk—even when ...
January 16,2026
Assessing methods for improving access to trauma care for ki...
January 15,2026
Portable device could help scientists track Alzheimer's dise...
January 14,2026
Neurons use physical signals, not electricity, to stabilize ...
January 13,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?Uses, Procedure, and ResultsByLynne Eldridge, MDUpdated on June 13, 2023Medically reviewed byDoru Paul,
Oncology March 17,2024
Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?Uses, Procedure, and ResultsByLynne Eldridge, MDUpdated on June 13, 2023Medically reviewed byDoru Paul,
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Dr. Fauci among hundreds who've contract...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
Announcement of the 2025 Nobel Prize in ...
More News
Get chronic UTIs? Future treatments may add more bacteria to your bladder to beat back harmful microbes

Get chronic UTIs? Future treatments may add more bacteria to your bladder to beat back harmful microbes

by Sarguru Subash,The ConversationEscherichia coli. Credit: Rocky Mountain Laboratories, NIAID, NIHMillions of peoplein the U.S. and around the world suffer from urinary tract infections e
Nephrology & Urology November 30,2024
Get chronic UTIs? Future treatments may add more bacteria to your bladder to beat back harmful microbes

Get chronic UTIs? Future treatments may add more bacteria to your bladder to beat back harmful microbes

by Sarguru Subash,The ConversationEscherichia coli. Credit: Rocky Mountain Laboratories, NIAID, NIHMillions of peoplein the U.S. and around the world suffer from urinary tract infections e
Nephrology & Urology November 30,2024
Study identifies data accessibility problems in clinical trials for new medicines

Study identifies data accessibility problems in clinical trials for new medicines

byFlinders UniversityCredit: Pixabay/CC0 Public DomainWhile substantial progress has been made in sharing data from clinical trials, many top-selling medicines still fall short when it comes to
Drug Discovery November 30,2024
Study identifies data accessibility problems in clinical trials for new medicines

Study identifies data accessibility problems in clinical trials for new medicines

byFlinders UniversityCredit: Pixabay/CC0 Public DomainWhile substantial progress has been made in sharing data from clinical trials, many top-selling medicines still fall short when it comes to
Drug Discovery November 30,2024
Study examines development of early COPD in ages 30 to 55

Study examines development of early COPD in ages 30 to 55

by COPD FoundationDistribution of Forced Expiratory Volume in 1 Second Trajectory from COPD Cohort Studies, Based on Presence or Absence of GOLD Grade ≥2 at the Final Exam. Credit:Chronic Obstru
Pulmonology November 30,2024
Study examines development of early COPD in ages 30 to 55

Study examines development of early COPD in ages 30 to 55

by COPD FoundationDistribution of Forced Expiratory Volume in 1 Second Trajectory from COPD Cohort Studies, Based on Presence or Absence of GOLD Grade ≥2 at the Final Exam. Credit:Chronic Obstru
Pulmonology November 30,2024
Basic research leads to drug candidates for fatal lung disease

Basic research leads to drug candidates for fatal lung disease

by Åsa Malmberg,Uppsala UniversityAnders Hallberg follows the work in the lab with interest. To his right is Marcus Söderström. Credit: Mikael WallerstedtDuring the 1990s, medicinal chemist Ande
Pulmonology November 30,2024
Basic research leads to drug candidates for fatal lung disease

Basic research leads to drug candidates for fatal lung disease

by Åsa Malmberg,Uppsala UniversityAnders Hallberg follows the work in the lab with interest. To his right is Marcus Söderström. Credit: Mikael WallerstedtDuring the 1990s, medicinal chemist Ande
Pulmonology November 30,2024
Low-dose ketamine shows promise for pain relief in emergency department patients

Low-dose ketamine shows promise for pain relief in emergency department patients

by Society for Academic Emergency MedicinePain intensity scores during the study period. The median is represented by the bold horizontal line within the box. The box defines the IQR. LDK, low-dose ke
Anesthesiology & Pain November 30,2024
Low-dose ketamine shows promise for pain relief in emergency department patients

Low-dose ketamine shows promise for pain relief in emergency department patients

by Society for Academic Emergency MedicinePain intensity scores during the study period. The median is represented by the bold horizontal line within the box. The box defines the IQR. LDK, low-dose ke
Anesthesiology & Pain November 30,2024
Treatment advances and predictive biomarkers stand to improve bladder cancer care

Treatment advances and predictive biomarkers stand to improve bladder cancer care

byUniversity of North Carolina Health CareCredit: AI-generated imageRecent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk
Oncology November 30,2024
Treatment advances and predictive biomarkers stand to improve bladder cancer care

Treatment advances and predictive biomarkers stand to improve bladder cancer care

byUniversity of North Carolina Health CareCredit: AI-generated imageRecent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk
Oncology November 30,2024
Transparency and reporting characteristics of randomized controlled trials with Chinese herbal medicine

Transparency and reporting characteristics of randomized controlled trials with Chinese herbal medicine

by Frontiers JournalsCredit:Frontiers of Medicine(2024). DOI: 10.1007/s11684-024-1092-4In 2017, the CONSORT-CHM Formulas 2017 extension was introduced to enhance the reporting transparency
Family Medicine November 30,2024
Transparency and reporting characteristics of randomized controlled trials with Chinese herbal medicine

Transparency and reporting characteristics of randomized controlled trials with Chinese herbal medicine

by Frontiers JournalsCredit:Frontiers of Medicine(2024). DOI: 10.1007/s11684-024-1092-4In 2017, the CONSORT-CHM Formulas 2017 extension was introduced to enhance the reporting transparency
Family Medicine November 30,2024
AI algorithm successfully matches potential volunteers to clinical trials

AI algorithm successfully matches potential volunteers to clinical trials

by NIH/National Library of MedicineA recent study found that TrialGPT could successfully identify eligible clinical trials for a given patient summary and provide an explanation for how the patient me
Technology & AI November 30,2024
AI algorithm successfully matches potential volunteers to clinical trials

AI algorithm successfully matches potential volunteers to clinical trials

by NIH/National Library of MedicineA recent study found that TrialGPT could successfully identify eligible clinical trials for a given patient summary and provide an explanation for how the patient me
Technology & AI November 30,2024
Steroid and surfactant mix fails to impact bronchopulmonary dysplasia in preterm infants

Steroid and surfactant mix fails to impact bronchopulmonary dysplasia in preterm infants

by Justin Jackson , Medical XpressCredit: Pixabay/CC0 Public DomainResearch led by the Royal Women's Hospital, Australia, has found that early intratracheal administration of budesonide mixed with
Pediatrics November 30,2024
Steroid and surfactant mix fails to impact bronchopulmonary dysplasia in preterm infants

Steroid and surfactant mix fails to impact bronchopulmonary dysplasia in preterm infants

by Justin Jackson , Medical XpressCredit: Pixabay/CC0 Public DomainResearch led by the Royal Women's Hospital, Australia, has found that early intratracheal administration of budesonide mixed with
Pediatrics November 30,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... Health spending has been rising across rich countries with different systems ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com